Market Cap 872.45M
Revenue (ttm) 370.50M
Net Income (ttm) 93.83M
EPS (ttm) N/A
PE Ratio 10.12
Forward PE N/A
Profit Margin 25.33%
Debt to Equity Ratio 0.00
Volume 1,046,700
Avg Vol 882,292
Day's Range N/A - N/A
Shares Out 63.36M
Stochastic %K 46%
Beta 1.97
Analysts Sell
Price Target $15.60

Company Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use...

Industry: Medical Devices
Sector: Healthcare
Phone: 972 4 909 6313
Address:
Tavor Building, Sha’ar Yokneam PO Box 533, Yokne'am, Israel
osubuck30
osubuck30 May. 6 at 5:06 PM
$INMD yeah they missed but subtract cash and only trading around $250 million market cap. Will do over $70 million in FCF. Starting a position.
0 · Reply
Remmers
Remmers May. 6 at 4:00 PM
$INMD this company blows.
0 · Reply
findingthestock
findingthestock May. 6 at 12:47 PM
$INMD Moshe is horrible but biggest issue is besides Morpheus everything else will not sell and grow like Morpheus did So many clients will be hesitant to buy and that’s been the case in North America There’s other products combined with other stuff that can achieve similar results That’s why Inmode has starting going into laser
1 · Reply
newscatch
newscatch May. 6 at 11:59 AM
$INMD https://www.prnewswire.com/news-releases/inmode-reports-first-quarter-2026-financial-results-quarterly-gaap-revenue-of-82-million-represents-5-year-over-year-increase-302763182.html
0 · Reply
Here4themoney1
Here4themoney1 May. 6 at 11:17 AM
$INMD utterly ridiculous. IF THIS FUCKING IDIOT IS NOT REMOVED AS CEO this will never ever grow again. It is not the sales teams, it is him with no ideas on how to fix it. Quit blaming macro and fucking wars, there are no wars where your product gets used you tard.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 6 at 11:07 AM
$INMD Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.18 down -30.77% YoY • Reported revenue of $82.02M up 5.32% YoY • Management expects InMode's full fiscal year 2026 revenues to be between $365M and $375M, with non-GAAP gross margin between 74% and 76%, and non-GAAP EPS between $1.33 and $1.38.
0 · Reply
watchCOM
watchCOM Apr. 15 at 4:18 PM
$INMD how is possible that it is not at 40 usd yet ?
0 · Reply
newscatch
newscatch Apr. 13 at 9:06 PM
$INMD https://www.prnewswire.com/news-releases/inmode-to-report-first-quarter-2026-financial-results-and-hold-conference-call-on-may-6--2026--expects-q1-revenue-between-81-5m-81-7m-reiterates-fy-2026-revenue-guidance-between-365m-375m-302739483.html
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 31 at 11:35 PM
$INMD RSI: 58.44, MACD: -0.1309 Vol: 0.25, MA20: 13.48, MA50: 14.19 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
future_tiger_cub
future_tiger_cub Mar. 18 at 12:06 AM
$INMD deadmoneyyy
0 · Reply
Latest News on INMD
InMode to Present at Upcoming Investor Conferences and Events

May 13, 2026, 8:30 AM EDT - 11 hours ago

InMode to Present at Upcoming Investor Conferences and Events


InMode price target lowered to $14 from $17 at Baird

2026-05-07T15:55:54.000Z - 6 days ago

InMode price target lowered to $14 from $17 at Baird


InMode price target lowered to $19 from $21 at Barclays

2026-05-07T11:59:20.000Z - 6 days ago

InMode price target lowered to $19 from $21 at Barclays


InMode reports Q1 adjusted EPS 25c, consensus 30c

2026-05-07T08:38:09.000Z - 6 days ago

InMode reports Q1 adjusted EPS 25c, consensus 30c


InMode sees FY26 adjusted EPS $1.33-$1.38, consensus $1.45

2026-05-07T08:36:11.000Z - 6 days ago

InMode sees FY26 adjusted EPS $1.33-$1.38, consensus $1.45


InMode CFO Yair Malca steps down

2026-05-07T08:32:48.000Z - 6 days ago

InMode CFO Yair Malca steps down


InMode Earnings Call Transcript: Q1 2026

May 6, 2026, 8:30 AM EDT - 7 days ago

InMode Earnings Call Transcript: Q1 2026


InMode announces new share repurchase program

2026-03-13T11:06:11.000Z - 2 months ago

InMode announces new share repurchase program


InMode Announces New Share Repurchase Program

Mar 13, 2026, 7:00 AM EDT - 2 months ago

InMode Announces New Share Repurchase Program


InMode to Present at Upcoming Investor Conferences

Feb 26, 2026, 8:00 AM EST - 2 months ago

InMode to Present at Upcoming Investor Conferences


InMode price target raised to $17 from $16 at Baird

2026-02-11T12:06:15.000Z - 3 months ago

InMode price target raised to $17 from $16 at Baird


InMode Earnings Call Transcript: Q4 2025

Feb 10, 2026, 8:30 AM EST - 3 months ago

InMode Earnings Call Transcript: Q4 2025


InMode reports Q4 non-GAAP EPS 46c, consensus 42c

2026-02-10T12:12:18.000Z - 3 months ago

InMode reports Q4 non-GAAP EPS 46c, consensus 42c


InMode sees 2026 non-GAAP EPS $1.43-$1.48, consensus $1.64

2026-02-10T12:11:50.000Z - 3 months ago

InMode sees 2026 non-GAAP EPS $1.43-$1.48, consensus $1.64


InMode Responds to Transaction Rumors

Feb 2, 2026, 7:00 AM EST - 3 months ago

InMode Responds to Transaction Rumors


InMode price target lowered to $15 from $16 at Canaccord

2025-12-17T12:21:37.000Z - 5 months ago

InMode price target lowered to $15 from $16 at Canaccord


InMode Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 11:00 AM EST - 6 months ago

InMode Transcript: Jefferies London Healthcare Conference 2025


InMode price target lowered to $16 from $16.25 at UBS

2025-11-06T13:30:32.000Z - 6 months ago

InMode price target lowered to $16 from $16.25 at UBS


InMode Earnings Call Transcript: Q3 2025

Nov 5, 2025, 8:30 AM EST - 6 months ago

InMode Earnings Call Transcript: Q3 2025


InMode reports Q3 adjusted EPS 38c, consensus 35c

2025-11-05T12:11:28.000Z - 6 months ago

InMode reports Q3 adjusted EPS 38c, consensus 35c


InMode Appoints Michael Dennison as President of North America

Nov 3, 2025, 8:05 AM EST - 6 months ago

InMode Appoints Michael Dennison as President of North America


InMode to Participate in Upcoming Investor Conferences

Oct 30, 2025, 8:30 AM EDT - 6 months ago

InMode to Participate in Upcoming Investor Conferences


InMode Transcript: Baird Global Healthcare Conference 2025

Sep 10, 2025, 8:30 AM EDT - 8 months ago

InMode Transcript: Baird Global Healthcare Conference 2025


InMode to Present at Baird 2025 Global Healthcare Conference

Sep 2, 2025, 8:30 AM EDT - 9 months ago

InMode to Present at Baird 2025 Global Healthcare Conference


InMode Earnings Call Transcript: Q2 2025

Jul 30, 2025, 8:30 AM EDT - 10 months ago

InMode Earnings Call Transcript: Q2 2025


InMode Transcript: BNP Virtual Aesthetics Day

May 19, 2025, 11:00 AM EDT - 1 year ago

InMode Transcript: BNP Virtual Aesthetics Day


InMode Earnings Call Transcript: Q1 2025

Apr 28, 2025, 8:30 AM EDT - 1 year ago

InMode Earnings Call Transcript: Q1 2025


InMode Responds to Doma Perpetual's Letters

Mar 6, 2025, 7:30 AM EST - 1 year ago

InMode Responds to Doma Perpetual's Letters


InMode Earnings Call Transcript: Q4 2024

Feb 6, 2025, 8:30 AM EST - 1 year ago

InMode Earnings Call Transcript: Q4 2024


InMode Transcript: UBS Global Healthcare Conference 2024

Nov 12, 2024, 5:00 PM EST - 1 year ago

InMode Transcript: UBS Global Healthcare Conference 2024


InMode Earnings Call Transcript: Q3 2024

Oct 30, 2024, 8:30 AM EDT - 1 year ago

InMode Earnings Call Transcript: Q3 2024


InMode Transcript: Baird's 2024 Global Healthcare Conference

Sep 10, 2024, 2:00 PM EDT - 1 year ago

InMode Transcript: Baird's 2024 Global Healthcare Conference


InMode to Present at 2024 Baird Global Healthcare Conference

Sep 4, 2024, 8:30 AM EDT - 1 year ago

InMode to Present at 2024 Baird Global Healthcare Conference


InMode Earnings Call Transcript: Q2 2024

Aug 1, 2024, 8:30 AM EDT - 1 year ago

InMode Earnings Call Transcript: Q2 2024


InMode Transcript: Jefferies Global Healthcare Conference

Jun 5, 2024, 7:30 AM EDT - 2 years ago

InMode Transcript: Jefferies Global Healthcare Conference


InMode to Present at Jefferies Healthcare Conference

May 16, 2024, 8:00 AM EDT - 2 years ago

InMode to Present at Jefferies Healthcare Conference


InMode Earnings Call Transcript: Q1 2024

May 2, 2024, 8:30 AM EDT - 2 years ago

InMode Earnings Call Transcript: Q1 2024


osubuck30
osubuck30 May. 6 at 5:06 PM
$INMD yeah they missed but subtract cash and only trading around $250 million market cap. Will do over $70 million in FCF. Starting a position.
0 · Reply
Remmers
Remmers May. 6 at 4:00 PM
$INMD this company blows.
0 · Reply
findingthestock
findingthestock May. 6 at 12:47 PM
$INMD Moshe is horrible but biggest issue is besides Morpheus everything else will not sell and grow like Morpheus did So many clients will be hesitant to buy and that’s been the case in North America There’s other products combined with other stuff that can achieve similar results That’s why Inmode has starting going into laser
1 · Reply
newscatch
newscatch May. 6 at 11:59 AM
$INMD https://www.prnewswire.com/news-releases/inmode-reports-first-quarter-2026-financial-results-quarterly-gaap-revenue-of-82-million-represents-5-year-over-year-increase-302763182.html
0 · Reply
Here4themoney1
Here4themoney1 May. 6 at 11:17 AM
$INMD utterly ridiculous. IF THIS FUCKING IDIOT IS NOT REMOVED AS CEO this will never ever grow again. It is not the sales teams, it is him with no ideas on how to fix it. Quit blaming macro and fucking wars, there are no wars where your product gets used you tard.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 6 at 11:07 AM
$INMD Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.18 down -30.77% YoY • Reported revenue of $82.02M up 5.32% YoY • Management expects InMode's full fiscal year 2026 revenues to be between $365M and $375M, with non-GAAP gross margin between 74% and 76%, and non-GAAP EPS between $1.33 and $1.38.
0 · Reply
watchCOM
watchCOM Apr. 15 at 4:18 PM
$INMD how is possible that it is not at 40 usd yet ?
0 · Reply
newscatch
newscatch Apr. 13 at 9:06 PM
$INMD https://www.prnewswire.com/news-releases/inmode-to-report-first-quarter-2026-financial-results-and-hold-conference-call-on-may-6--2026--expects-q1-revenue-between-81-5m-81-7m-reiterates-fy-2026-revenue-guidance-between-365m-375m-302739483.html
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 31 at 11:35 PM
$INMD RSI: 58.44, MACD: -0.1309 Vol: 0.25, MA20: 13.48, MA50: 14.19 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
future_tiger_cub
future_tiger_cub Mar. 18 at 12:06 AM
$INMD deadmoneyyy
0 · Reply
devd7
devd7 Mar. 16 at 7:02 PM
$ESLT I don’t companies from Israel. Just look at $INMD for example. Yeah they might push it up because of current situation but this has ran up too much . Iran only has 8% of its ammunition left. War will end fast.
0 · Reply
IowaInvest11
IowaInvest11 Mar. 14 at 4:24 PM
$INMD Classic case of a value trap 4 years ago. All the low hanging fruit high margin sales were already sold and growth could not be sustained. Although buying down here may be a good choice if patient enough
1 · Reply
findingthestock
findingthestock Mar. 14 at 4:31 AM
$INMD HAVE WE HIT BOTTOM
0 · Reply
StockElementCorporation
StockElementCorporation Mar. 13 at 12:49 PM
Premarket movers 📈 Upside: $PAYP +22% — post-IPO strength $KLAR +7.5% — insider buying $INMD +6.4% — share buyback $NIO +3.5% — analyst upgrade $TNXP +3.4% — earnings RBRK +2.1% — earnings Downside: KLC -34% — earnings
0 · Reply
newscatch
newscatch Mar. 13 at 11:54 AM
$INMD https://www.prnewswire.com/news-releases/inmode-announces-new-share-repurchase-program-302712849.html
0 · Reply
OpenOutcrier
OpenOutcrier Mar. 13 at 11:51 AM
$INMD (+4.9% pre) InMode authorizes share buyback program for 6.38 million shares https://ooc.bz/l/96596
0 · Reply
DonCorleone77
DonCorleone77 Mar. 13 at 11:04 AM
$INMD InMode announces new share repurchase program InMode announced that its Board of Directors has authorized a new share repurchase program for up to approximately 10% of the company's total shares outstanding, representing approximately 6.38M ordinary shares. In 2025, the company repurchased approximately $127.4M of its outstanding ordinary shares through share repurchase programs. Despite a challenging macroeconomic environment, the company continues to generate strong cash flow and believes that repurchasing shares at its current valuation represents an attractive use of capital.
0 · Reply
findingthestock
findingthestock Mar. 9 at 2:24 PM
$INMD this is going to single digits
1 · Reply
JeanPhi
JeanPhi Mar. 6 at 10:04 PM
$INMD 36$ or nothing...
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 4 at 4:32 AM
$INMD Share Price: $13.59 Contract Selected: Aug 21, 2026 $15 Calls Buy Zone: $0.59 – $0.73 Target Zone: $0.98 – $1.19 Potential Upside: 55% ROI Time to Expiration: 170 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
cupierjack
cupierjack Feb. 27 at 8:49 PM
$INMD What's stopping the company that wants to take over Inmode at $18 from starting to buy shares like crazy at those prices? If they're so eager to control the company, they should start now.
4 · Reply
i_jw
i_jw Feb. 27 at 8:48 PM
$INMD This is looking pretty interesting. I dont think we have seen the last of takeover interest. And this co has a history of large buybacks. Trading at 2.5x EV/FCF here.
0 · Reply